Found 20 matching trials
A Placebo Controlled Study Comparing AZD1775+ Docetaxel Versus Placebo+Docetaxel to Treat Lung Cancer PHASE2 A Lead-in Phase II Multicentre, Randomised, Double-Blind Study Comparing AZ...
Show More Learn More & Join Trial
Monotherapy With Eribulin In Her2 Negative Metastatic Breast Cancer as a First Line Treatment PHASE2 Multicentre, prospective, non-controlled phase II clinical trial to evaluat...
Show More Location
Multiple Locations
Learn More & Join Trial
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors PHASE2 The primary objective of this study is to improve the 2-year progression-fr...
Show More Location
Aflac Cancer & Blood Disorders Centers
Learn More & Join Trial
Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer. PHASE1 The purpose of this study is to determine the optimally-tolerated regimens ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Pharmacogenetic Study of Antimitotic Therapies Involved in Hepatic VOD in Children With Nephroblastoma or ALL NA Hepatic veno-occlusive diseases (VOD) during cancer treatment in children a...
Show More Location
Univesity Hostipal of Amiens
Learn More & Join Trial
Evaluation of IPI-549 Combined With Front-line Treatments in Pts. With Triple-Negative Breast Cancer or Renal Cell Carcinoma PHASE2 MARIO-3 is a Phase 2 multi-arm combination cohort study designed to evaluat...
Show More Location
Ironwood Cancer and Research Center
Learn More & Join Trial
A Study of ARRY-334543 and Docetaxel in Patients With Advanced Cancer PHASE1 This is a Phase 1 study during which patients with advanced/metastatic soli...
Show More Location
University of Colorado Health Sciences Center
Learn More & Join Trial
Denintuzumab Mafodotin (SGN-CD19A) Combined With RCHOP or RCHP Versus RCHOP Alone in Diffuse Large B-Cell Lymphoma or Follicular Lymphoma PHASE2 This is a Phase 2 study to evaluate the combination of denintuzumab mafodot...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
Pulsed Dose Chemotherapy Plus Pembrolizumab in Recurrent/Metastatic HNSCC PHASE2 The rationale for the new sequence of pulsed dose chemotherapy proposed in ...
Show More Location
UPMC Hillman Cancer Center
Learn More & Join Trial
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer PHASE2 This Phase 2, open-label, randomized study in non-small-cell lung cancer (N...
Show More Location
Pioneer Research Center, LLC
Learn More & Join Trial